Brief: Nautilus Bio Entered Sales Agreement With Cowen And Company To Sell Shares Of Common Stock Having Proceeds Of Up To $125 Mln
28/02/2024 12:29
Feb 28 (Reuters) - Nautilus Biotechnology Inc NAUT.O :
* NAUTILUS BIOTECHNOLOGY - ENTERED SALES AGREEMENT WITH
COWEN AND
COMPANY TO SELL SHARES OF CO'S COMMON STOCK HAVING PROCEEDS OF
UP TO $125 MILLION
Source text for Eikon: ID:n0001628280-24-007395
Further company coverage: NAUT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11